Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
暂无分享,去创建一个
I. Tomlinson | F. Castro-Giner | P. McHugh | R. Carter | R. Chetty | J. Cazier | C. Kartsonaki | F. Buffa | M. Middleton | N. Sahgal | R. Gillies | N. Maynard | J. Findlay | R. Sharma | L. Wang | T. Macgregor